Comparison between Anthem Biosciences IPO and Jajoo Rashmi Refractories IPO.
Anthem Biosciences IPO is a Mainboard Bookbuilding IPO proposed to list at BSE, NSE while Jajoo Rashmi Refractories IPO is a Mainboard Bookbuilding proposed to list at BSE, NSE.
The total issue size of Anthem Biosciences IPO is up to ₹3,395.00 Cr whereas the issue size of the Jajoo Rashmi Refractories IPO is up to ₹150.00 Cr. The final issue price of Anthem Biosciences IPO is ₹570.00 per share and of Jajoo Rashmi Refractories IPO is .
| Anthem Biosciences IPO | Jajoo Rashmi Refractories IPO | |
|---|---|---|
| Face Value | ₹2 per share | ₹10 per share |
| Issue Price (Lower) | ₹540.00 per share | |
| Issue Price (Upper) | ₹570.00 per share | |
| Issue Price (Final) | ₹570.00 per share | |
| Discount (Retail) | ||
| Discount (Employee) | ₹50.00 per share | |
| Market Lot Size | 26 shares | |
| Fresh Issue Size | 0 shares | 0 shares |
| Fresh Issue Size (Amount) | up to ₹0.00 Cr | up to ₹150.00 Cr |
| OFS Issue Size | 5,95,75,319 shares | 0 shares |
| OFS Issue Size (Amount) | up to ₹3,395.00 Cr | up to ₹0.00 Cr |
| Issue Size Total | 5,95,75,319 shares | 0 shares |
| Issue Size Total (Amount) | up to ₹3,395.00 Cr | up to ₹150.00 Cr |
Anthem Biosciences IPO opens on Jul 14, 2025, while Jajoo Rashmi Refractories IPO opens on . The closing date of Anthem Biosciences IPO and Jajoo Rashmi Refractories IPO is Jul 16, 2025, and , respectively.
| Anthem Biosciences IPO | Jajoo Rashmi Refractories IPO | |
|---|---|---|
| Anchor Bid Date | Jul 11, 2025 | |
| Issue Open | Jul 14, 2025 | |
| Issue Close | Jul 16, 2025 | |
| Basis Of Allotment (Tentative) | Jul 17, 2025 | |
| Initiation of Refunds (Tentative) | Jul 18, 2025 | |
| Credit of Share (Tentative) | Jul 18, 2025 | |
| Listing date (Tentative) | Jul 21, 2025 | |
| Anchor Lockin End date 1 | Aug 15, 2025 | |
| Anchor Lockin End date 2 | Oct 14, 2025 |
Anthem Biosciences IPO P/E ratio is 70.62, as compared to Jajoo Rashmi Refractories IPO P/E ratio of .
| Anthem Biosciences IPO | Jajoo Rashmi Refractories IPO | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | Company Financials (Restated)Anthem Biosciences Ltd.'s revenue increased by 30% and profit after tax (PAT) rose by 23% between the financial year ending with March 31, 2025 and March 31, 2024.
| Company Financials (Restated Consolidated)
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 76.87 | 98.74 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | 74.68 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | 70.62 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ₹31867.39 Cr. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | 20.82% | 31.42% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | 26.88% | 28.55% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | 0.05 | 0.43 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ₹8.07 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | 20.82% | 31.42% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the Anthem Biosciences IPO Retail Individual Investors (RII) are offered 2,07,95,834 shares while in Jajoo Rashmi Refractories IPO retail investors are offered 2,07,95,834 shares. Qualified Institutional Buyers (QIB) are offered 1,18,83,333 shares in Anthem Biosciences IPO and in Jajoo Rashmi Refractories IPO.
| Anthem Biosciences IPO | Jajoo Rashmi Refractories IPO | |
|---|---|---|
| Anchor Investor Reservation | 1,78,24,999 shares | |
| Market Maker Reservation | 0 shares | |
| QIB | 1,18,83,333 shares | |
| NII | 89,12,500 shares | |
| RII | 2,07,95,834 shares | |
| Employee | 1,58,653 shares | |
| Others | ||
| Total | 5,95,75,319 shares |
Anthem Biosciences IPO subscribed 67.42x in total, whereas Jajoo Rashmi Refractories IPO subscribed .
| Anthem Biosciences IPO | Jajoo Rashmi Refractories IPO | |
|---|---|---|
| QIB (times) | 192.80x | |
| NII (times) | 44.70x | |
| Big NII (times) | 51.66x | |
| Small NII (times) | 30.80x | |
| RII (times) | 5.98x | |
| Employee (times) | 6.99x | |
| Other (times) | ||
| Total (times) | 67.42x |
